|Articles|March 1, 2013
- Pharmaceutical Executive-03-01-2013
- Volume 0
- Issue 0
PE, March 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 13 years ago
Less Selling, More Timeover 13 years ago
Test and Learn: Making Confident Decisions on the Commercial Sideover 13 years ago
China and the Emerging Markets Challengeover 13 years ago
Embedding Market Access in Today's Pharma Business Modelover 13 years ago
Who's Really in Charge of European Drug Registration?over 13 years ago
Brand of the Year: Januviaover 13 years ago
Early Engagement with Medical Laboratoriesover 13 years ago
Pharma in the News: Pharm Exec's Annual Press Auditover 13 years ago
Safeguarding the Value of Patent AssetsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5